Innovative Licensing and Access Pathway
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Read the press release from Medicines and Healthcare products Regulatory Agency published on 27 January 2023.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (13 février 2023). Innovative Licensing and Access Pathway. ELSIBI. Consulté le 10 décembre 2024 à l’adresse https://doi.org/10.58079/o68k
